Cargando…

The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?

Despite many advances in the management of hypertensive chronic kidney disease (CKD) patients, both on and off dialysis, there exist several gaps in our knowledge. Although the modern techniques to measure blood pressure (BP) indirectly have been available for a long time, among those with CKD, how...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwal, Rajiv, Martinez-Castelao, Alberto, Wiecek, Andrzej, Massy, Ziad, Suleymanlar, Gultekin, Ortiz, Alberto, Blankestijn, Peter J, Covic, Adrian, Dekker, Friedo W, Jager, Kitty J, Lindholm, Bengt, Goldsmith, David, Fliser, Danilo, London, Gerard, Zoccali, Carmine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Mini Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089679/ https://www.ncbi.nlm.nih.gov/pubmed/25018898 http://dx.doi.org/10.1038/kisup.2011.1

Ejemplares similares

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda
por: Fliser, Danilo, et al.
Publicado: (2011)

Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease
por: London, Gerard, et al.
Publicado: (2011)

Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems
por: Blankestijn, Peter J, et al.
Publicado: (2011)

Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?
por: Jager, Kitty J, et al.
Publicado: (2011)

The complexity of the cardio–renal link: taxonomy, syndromes, and diseases
por: Zoccali, Carmine, et al.
Publicado: (2011)

Promoting scientific collaboration and education in cardiovascular–renal medicine: EURECAM: An ERA-EDTA-based working group
por: Covic, Adrian, et al.
Publicado: (2009)

Understanding the lingering consequences of what we treat and what we do
por: Angus, Derek C
Publicado: (2004)

A new series of advanced-level research methods papers
por: Jager, Kitty J, et al.
Publicado: (2020)

Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
por: Górriz, Jose Luis, et al.
Publicado: (2015)

Handgrip strength evaluation in CKD: do we have enough evidence?
por: Leal, Viviane O., et al.
Publicado: (2020)

A new methodological series in CKJ: from basic-level methodology to artificial intelligence in medicine
por: Zoccali, Carmine, et al.
Publicado: (2023)

What should European nephrology do with the new CKD-EPI equation?
por: Gansevoort, Ron T, et al.
Publicado: (2022)

How do We Manage Coronary Artery Disease in Patients with CKD and ESRD?
por: Choi, Hoon Young, et al.
Publicado: (2014)

Experiencing mathematics: what do we do, when we do mathematics?
por: Hersh, Reuben
Publicado: (2014)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Should we treat pyrexia? And how do we do it?
por: Doyle, James F., et al.
Publicado: (2016)

What Do We Talk About When We Talk About Frailty?
por: Falchetti, Alberto, et al.
Publicado: (2021)

What do we do and how do we do it? Assessing genetic counselling in the modern era
por: Yeates, Laura, et al.
Publicado: (2020)

Preoperative anxiety: what are we really doing?
por: Buonanno, Pasquale, et al.
Publicado: (2021)

Myelography in the Age of MRI: Why We Do It, and How We Do It
por: Ozdoba, Christoph, et al.
Publicado: (2011)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Globalization of spine care: how are we doing and what are we doing?
por: Chapman, Jens
Publicado: (2012)

Malaria: How Are We Doing and How Can We Do Better?
por: Rosenthal, Philip J., et al.
Publicado: (2019)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Reply to ‘Depression and clinical outcomes in CKD: do anti-depressants play a role? (EQUAL Study)’
por: Eveleens Maarse, Boukje C, et al.
Publicado: (2022)

The risk of viral transmission in feed: What do we know, what do we do?
por: Dee, Scott A., et al.
Publicado: (2020)

EBCOG: European Board and College of Obstetrics and Gynaecology: Who are we? What do we do? Where do we go?
por: Hornnes, P., et al.
Publicado: (2010)

Do We Mean What We Say?
por: Towner, Ausburn
Publicado: (1885)

Why do we Need Quality Articles, What are we Going to do With?
por: Mueen Ahmed, KK
Publicado: (2011)

Particle Physics Outreach: What we are doing and what we could be doing
por: Goldfarb, Steven
Publicado: (2018)

Do we protect freshwater eels or do we drive them to extinction?
por: Arai, Takaomi
Publicado: (2014)

What Do We Want? INHIBITION. When Do We Want it? NOW
por: Maguire, Jamie L.
Publicado: (2019)

COVID-19 vaccine: what are we doing and what should we do?
por: Candelli, Marcello
Publicado: (2022)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Keeping the Journal in the Second Quarter: What Are We Doing and What Will We Do?
por: Altay, Servet
Publicado: (2023)

Translational research in nephrology: prognosis
por: Tripepi, Giovanni, et al.
Publicado: (2021)

External validation of prognostic models: what, why, how, when and where?
por: Ramspek, Chava L, et al.
Publicado: (2020)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Do we need elastography for EUS?
por: Dietrich, Christoph F., et al.
Publicado: (2020)

3D transoesophageal echocardiography in the TAVI sizing arena: should we do it and how do we do it?
por: Bleakley, Caroline, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ochdbvh1odgvujkn74t1octra5